Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration
1 other identifier
observational
128
1 country
1
Brief Summary
The study hypothesis is that patients with dry age-related macular degeneration experience visual function impairments such as defects in dark adaptation, glare intolerance, poor light transition and reading in low lighting conditions. Studies have shown that patients in the early phases of AMD with normal visual acuity commonly reported difficulty with these visual functions but there have been no systematic studies evaluating these deficits in this population. This prospective, exploratory study will include up to 130 patients with dry AMD and 60 controls. These patients will undergo the following non-invasive visual function testing:
- microperimetry with eye tracking
- low luminance visual acuity
- specialized color vision (cone-specific)
- contrast testing and night vision testing. High-resolution spectral domain optical coherence tomography (SDOCT) images will be taken of the central retina using the Spectralis OCT unit. The values of visual function tested will be correlated with the findings on SDOCT (volume/amount of drusen present in early AMD). There are no known risks to the subjects beyond what is normal for standard examinations of the eye, visual function testing and standard ocular photographic procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 28, 2013
CompletedFirst Posted
Study publicly available on registry
April 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedApril 17, 2019
February 1, 2019
5.3 years
March 28, 2013
April 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in low luminance visual acuity
Arm 1: 1-2 months. Arm 2: 6, 12, 18 and 24 months
Secondary Outcomes (3)
Change in cone specific contrast sensitivity
Arm 1: 1-2 months. Arm 2: 6, 12, 18 and 24 months
Change in contrast sensitivity
Arm 1: 1-2 months. Arm 2: 6, 12, 18 and 24 months
Change in macular sensitivity on microperimetry
Arm 1: 1-2 months. Arm 2: 6, 12, 18 and 24 months
Study Arms (2)
Normal
Age-related macular degeneration
Eligibility Criteria
Subjects will be identified from patients of the Duke Eye Center presenting for ophthalmologic consultation. Patients with dry AMD are routinely available from this clinic and will be the primary study group.
You may qualify if:
- Capable and willing to provide consent
- Has been diagnosed with dry age-related macular degeneration stages 1-3
- At least 50 years of age
You may not qualify if:
- Unable or unwilling to give consent
- Under 50 years of age
- Presence of retinal pathology such as central geographic atrophy, hemorrhage or retinal fluid, and other macular pathology other than AMD
- Presence of dense cataracts in the study eye(s) that can affect visual function tests
- Presence of glaucoma requiring treatment during the study and/or visual field defects
- Presence retinal laser or surgical theraphy in study eye (s)
- Any of other ocular condition requiring long-term theraphy or surgery during the study
- Participant has photographically significant corneal or media opacities in either eye that would preclude adequate ophthalmic imaging and functional testing
- Diagnosis of nystagmus that will interfere with testing
- High myopia -8 Diopters or more severe
- Participant has, in the opinion of the Investigator, any physical or mental condition that would increase the risk of participation in the stduy or may interfere with the study procedures, evaluations and outcome assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Hoffmann-La Rochecollaborator
Study Sites (1)
Duke Eye Center
Durham, North Carolina, 27710, United States
Related Publications (2)
Cocce KJ, Stinnett SS, Luhmann UFO, Vajzovic L, Horne A, Schuman SG, Toth CA, Cousins SW, Lad EM. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints. Am J Ophthalmol. 2018 May;189:127-138. doi: 10.1016/j.ajo.2018.02.012. Epub 2018 Mar 15.
PMID: 29477964RESULTThompson AC, Luhmann UFO, Stinnett SS, Vajzovic L, Horne A, Toth CA, Cousins SW, Lad EM. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):289-297. doi: 10.1167/iovs.17-22528.
PMID: 29340643RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eleonora Lad, MD, PhD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2013
First Posted
April 2, 2013
Study Start
March 1, 2013
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
April 17, 2019
Record last verified: 2019-02